Optiemus targets 25 million protectors monthly by March 2027

Optiemus Infracom Ltd. plans 25 million screen protectors of monthly manufacturing capacity by March 2027, comprising a 5 million-piece Noida brownfield expansion and a 20 million-piece leased greenfield plant, ahead of mandatory BIS certification effective April 1, 2027.

What is Optiemus building before the BIS deadline?

Optiemus is building a two-facility screen-protector network with planned combined capacity of 25 million pieces a month by March 2027. The plan combines an expansion at its existing Noida plant, from 2 million to 5 million pieces a month, with a new facility designed for 20 million pieces a month.

The brownfield element is the existing Noida plant, which the presentation says was inaugurated by Shri Ashwini Vaishnav last year. Optiemus expects capacity there to rise by 3 million pieces a month, or 150%, from 2 million to 5 million pieces, with the expanded facility expected to come on stream in January 2027.

The second element is a pre-constructed greenfield plant covering 4,00,000 square metres and designed to manufacture 20 million pieces a month. Optiemus says it secured ready infrastructure under a long-term lease, which it says fast-tracks capital expenditure, and expects the facility to be operational by March 2027.

Why does the April 2027 BIS requirement matter for Optiemus?

The April 1, 2027 BIS certification requirement matters because Optiemus identifies screen protectors as an imports-only market and describes mandatory certification as an import-substitution opportunity. The company puts the market at Rs 20,000 crore at consumer prices and says its potential could reach Rs 40,000 crore by 2030.

Optiemus has aligned its January 2027 and March 2027 commissioning targets with the April 2027 regulatory date. The 5 million-piece brownfield facility is expected before the mandate, while the 20 million-piece greenfield plant is also scheduled to be operating before certification becomes mandatory.

The presentation describes the Noida manufacturing process as in-house dual-stage chemical tempering, rather than assembly alone. It also presents RHINOTECH as engineered by Corning, linking the planned domestic production programme to the company’s stated Make in India positioning.

Which screen-protector products will Optiemus offer?

Optiemus plans four named products: SCREENlife, OPTIGUARD, RHINOTECH and KAVACH. SCREENlife is assigned to the Protection segment, OPTIGUARD to Protection Plus and RHINOTECH to Protection Pro, while KAVACH is presented as a separate display-protection package.

SCREENlife is described as genuine tempered glass. OPTIGUARD is described as a genuine screen protector with a fog-marked feature for authenticity, and RHINOTECH is described as genuine tempered glass engineered by Corning and carrying a fog mark. The presentation does not disclose retail prices, launch dates, material specifications or expected sales volumes for these three products.

KAVACH includes two tempered glasses and one-time screen replacement. Optiemus presents the package as offering 365 days of full coverage and built-in screen insurance, while stating that there are no hidden costs; the presentation does not provide policy exclusions, an insurer name, claims terms or the economics of the replacement benefit.

How will Optiemus sell its screen protectors?

Optiemus plans to sell screen protectors through three routes: online channels, offline or mainline shops, and organised retail. This proposed omnichannel model sits alongside the March 2027 target for 25 million pieces of monthly capacity, but the presentation does not identify marketplaces, retail chains, distributors or launch locations.

The channel programme would carry products across three protection segments, namely SCREENlife, OPTIGUARD and RHINOTECH, as well as the KAVACH package with two glasses and a one-time display replacement. Optiemus calls the business-to-consumer category scalable, branded and high-margin, but does not report revenue, unit sales or margin figures for the category.

The planned supply increase is concentrated in two stages: 5 million pieces a month at the Noida site from January 2027 and 20 million pieces a month at the leased greenfield plant from March 2027. Optiemus has not disclosed how the 25 million-piece capacity would be allocated between online, mainline and organised-retail channels.

What remains unconfirmed in Optiemus's plan?

The principal unconfirmed operational matters are whether the brownfield expansion will come on stream in January 2027 and whether the 20 million-piece greenfield plant will be operational in March 2027. These are expected dates in the presentation, rather than reported commissioning, certified production, customer orders or revenue milestones.

Optiemus states that BIS certification becomes mandatory on April 1, 2027, but does not describe its certification process or identify product variants that will be certified. The source also does not disclose capital expenditure for the 4,00,000-square-metre leased site, production utilisation assumptions or the intended share of the Rs 20,000 crore market.

Commercial details are similarly absent from the disclosed plan. Optiemus names four products and three sales routes, but gives no selling prices, channel partners, distribution spending, revenue target or timing for a commercial launch beyond the January 2027 and March 2027 manufacturing milestones.

Conclusion

Optiemus’s disclosed strategy combines a 150% expansion of the existing Noida plant with a 20 million-piece greenfield facility, creating a proposed 25 million-piece monthly network. The portfolio spans three protection segments through SCREENlife, OPTIGUARD and RHINOTECH, while KAVACH adds a two-glass package with one-time screen replacement.

The next disclosed milestones are the January 2027 brownfield start-up, the March 2027 greenfield operating target and mandatory BIS certification from April 1, 2027. The presentation leaves certification execution, capacity utilisation, product pricing, channel partners and sales outcomes unresolved.